MFN2 and Charcot-Marie-Tooth disease: In 2017, we reported a nationwide study analyzing 79 Japanese patients with genetically confirmed MFN2 variants [5] that confirmed the clinical variability of MFN2‐related CMT and revealed several genotype–phenotype associations specific to the Japanese population.